From an epidemiological standpoint, the widespread use of AAVs in gene therapy has significant implications. By providing potential cures or long-term treatments for previously untreatable genetic conditions, AAV-based therapies can reduce the prevalence of these disorders, improve quality of life, and decrease healthcare costs. Additionally, understanding the distribution and prevalence of AAVs in the population can help in the development of more effective and targeted therapies.
